DMPHF Stock: Dermapharm Holding SE Stock Price, Analysis & Insights
Get live DMPHF stock price $39.56, comprehensive Dermapharm Holding SE stock analysis, charts, news, and expert forecast. Real-time DMPHF stock data and investment insights.
Loading chart data...
Dermapharm Holding SE (DMPHF) Overview
Dermapharm Holding SE (DMPHF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, DMPHF trades at $39.56 with a market capitalization of 1.96B . Over the past 52 weeks, DMPHF has traded between $39.56 and $59.00 , with the current price positioned at approximately 0% of this range ....
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 1.96B
- Current price: $39.56
- 52-week range: $39.56 - $59.00
- P/E ratio: 17.90
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Dermapharm Holding SE is an international pharmaceutical company specializing in off-patent branded medications, serving both domestic and global markets. Its business is structured across three distinct segments: Branded Pharmaceuticals and Other He...
Company Information
- CEO
- Hans-Georg Feldmeier
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 3610
Contact Information
- Website
- https://www.dermapharm.de
- Address
- Lil-Dagover-Ring 7
- Country
- DE
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 17.9)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Dermapharm Holding SE shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Dermapharm Holding SE
- ⚠Investors should consider how Dermapharm Holding SE fits within their overall portfolio allocation
Market Cap
1.96B
P/E Ratio (TTM)
17.90
Beta
0.88
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare DMPHF with peer companies:
- Price
- $26.53
- Market cap
- 1.95B
- Price
- $35.00
- Market cap
- 3.11B
- Price
- $3.10
- Market cap
- 1.08B
- Price
- $1.35
- Market cap
- 3.27B
- Price
- $10.83
- Market cap
- 2.86B
- Price
- $2.16
- Market cap
- 1.86B
- Price
- $29.00
- Market cap
- 2.04B
- Price
- $15.35
- Market cap
- 3.30B
- Price
- $0.19
- Market cap
- 1.69B
- Price
- $23.20
- Market cap
- 1.73B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.